.webp)
The surgery of the future will be based on advanced technological tools:
• Real-time medical imaging and augmented reality;
• AI-assisted surgical robots, such as those developed by Genesis MedTech in Asia;
- Light analgesia (hypnosis, local anaesthesia) to speed up post-operative recovery;
- Tools to protect healthcare professionals from the risks associated with exposure to hazardous drugs and vapors;
- State-of-the-art defibrillators and connected solutions.
Equashield: Israeli innovation for caregiver safety
Behind the scenes in hospitals, hundreds of thousands of doctors and nurses handle hazardous drugs on a daily basis, exposing their health to invisible risks. To protect them, Equashield, founded in 2009 by Marino Kriheli and Eric Shem-Tov, has developed a pioneering technology: closed transfer devices (CSTDs).
Their flagship product, the Equashield CSTD, features a unique design incorporating a pressure equalization system, a metal-backed syringe and a dry disconnection mechanism, guaranteeing a total seal. This innovation has made Equashield the world leader in CSTDs, with sales on five continents and over 3,000 customers.
In 2022, the company strengthened its strategic position by welcoming Nordic Capital as a major shareholder, supporting its growth and expansion.
Equashield doesn't just protect caregivers: it is also revolutionizing drug preparation with Equashield Pro, an automated compounding system using artificial intelligence to optimize process safety and efficiency.
Genesis MedTech and its robot-assisted surgeries
Founded in 2019, Genesis MedTech has rapidly established itself as a key player in the medical device sector, particularly in emerging markets. The company develops and markets innovative medical technologies in the fields of surgery, cardiology and vascular interventions, with a particular focus on Asia.
Genesis MedTech's global headquarters are located in Singapore, a strategic choice that enables the company to effectively serve the fast-growing Asian markets. In addition, the company has established an innovation and manufacturing center in Wuxi, China, covering an area of 135,333 m². This campus houses research and development centers, as well as production facilities, and is expected to reach full-scale industrial production with a production value of over $1.38 billion in the next three to five years.
In February 2025, Genesis MedTech reached a milestone by performing its first robot-assisted surgeries at Clínica Andes Salud Concepción in Chile, marking a significant milestone in surgical innovation.
With a global team of over 500 employees and a presence in more than 2,000 hospitals across China, Genesis MedTech continues to expand its product portfolio and strengthen its R&D capabilities to meet the growing needs of emerging markets.
Palex Medical: the quiet force of European MedTech
Since its foundation in 1955, Palex Medical has established itself as a key player in the distribution of high value-added medical devices in Southern Europe. With over 150,000 part numbers and more than 600 partnerships with leading manufacturers, the company offers a wide range of products in fields such as radiotherapy, surgery, neonatology, endoscopy, cardiology and infection management.
Palex Medical stands out for its unique business model, offering its manufacturing partners an integrated sales and distribution channel, while adding value thanks to its local expertise and in-depth knowledge of the Spanish, Portuguese and Italian markets.
In 2024, the company took a major step forward with the acquisition of Duomed, a Belgian distributor of medical devices specializing in areas such as endoscopy, surgery, critical care, medical imaging and physiological monitoring.
With over 930 employees and sales of 660 million euros in 2024, Palex Medical continues to expand its product portfolio and strengthen its R&D capabilities to meet the growing needs of healthcare professionals.
corpuls reinvents emergency equipment
When it comes to life-saving treatment, every second counts. Since it was founded in 1982 by Peter Hünemörder, corpuls, a German company specializing in cardio-thoracic equipment, has been committed to providing robust, reliable solutions for hospitals and emergency services.
Its innovations:
• State-of-the-art defibrillators: designed for use in extreme environments, their devices save lives in critical situations.
• Connected solutions: their cardiac monitors send data in real time to hospitals, allowing preparation in advance of patient arrival.
• Exceptional durability: each piece of equipment is designed to withstand the harsh conditions encountered by emergency teams, whether it's a road accident or a mountain rescue.
Today, corpuls equips hundreds of hospitals in over 60 countries, and generated sales of 155 million euros in 2024.
As the demand for healthcare technology continues to grow, these companies are at the forefront of a major transformation. Their vision, driven by bold founders and talented teams, shows how innovation and compassion can combine to redefine the standards of medicine.
